Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCR

Julio A. Ramírez(Norton Healthcare), Elizabeth Begier(Pfizer (United States)), Thomas Chandler(Norton Healthcare), Paula Peyrani(University of Louisville), Alan D. Junkins(Norton Healthcare), Sonali Trivedi(Tongji University), Paul E. Schulz(The University of Texas Health Science Center at Houston), Bradford D. Gessner(Pfizer (United States)), Kari Yacisin(Pfizer (United States)), Warren V. Kalina(Pfizer (United States)), Luis Jódar(Pfizer (United States)), Ruth Carrico(University of Louisville), Edward E. Walsh(University of Rochester), Stephen Furmanek(Norton Healthcare), Ann R. Falsey(University of Rochester), Qing Liu(Hong Kong Polytechnic University), Ashley M Wilde(Norton Healthcare), Robin Hubler(Pfizer (United States)), Sonal Uppal(Pfizer (United States))
Infectious Diseases and Therapy
May 6, 2023
10.1007/s40121-023-00805-1
Cited by 109

Related Papers

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
|New England Journal of Medicine|2005|2.2k